Statin as a Combined Therapy for Advanced-Stage Ovarian Cancer: A Propensity Score Matched Analysis

Background. Despite the great achievements in the treatment of advanced-stage ovarian cancer, it is still a severe condition with an unfavorable 5-year survival rate. Statins have been suggested to reduce the risk of several cancers beyond their cholesterol-lowing effects. However, the prognostic si...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hong-Yu, Wang, Qian, Xu, Qiu-Hong, Yan, Li, Gao, Xue-Feng, Lu, Yan-Hong, Wang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5128698/
https://www.ncbi.nlm.nih.gov/pubmed/27975064
http://dx.doi.org/10.1155/2016/9125238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5128698/
https://www.ncbi.nlm.nih.gov/pubmed/27975064
http://dx.doi.org/10.1155/2016/9125238

Ejemplares similares